Literature DB >> 11905824

Vaccine safety--vaccine benefits: science and the public's perception.

C B Wilson1, E K Marcuse.   

Abstract

The development of cowpox vaccination by Jenner led to the development of immunology as a scientific discipline. The subsequent eradication of smallpox and the remarkable effects of other vaccines are among the most important contributions of biomedical science to human health. Today, the need for new vaccines has never been greater. However, in developed countries, the public's fear of vaccine-preventable diseases has waned, and awareness of potential adverse effects has increased, which is threatening vaccine acceptance. To further the control of disease by vaccination, we must develop safe and effective new vaccines to combat infectious diseases, and address the public's concerns.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11905824     DOI: 10.1038/35100585

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  14 in total

1.  Evaluating the safety of new vaccines: summary of a workshop.

Authors:  Susan S Ellenberg; Mary A Foulkes; Karen Midthun; Karen L Goldenthal
Journal:  Am J Public Health       Date:  2005-05       Impact factor: 9.308

Review 2.  Adversomics: a new paradigm for vaccine safety and design.

Authors:  Jennifer A Whitaker; Inna G Ovsyannikova; Gregory A Poland
Journal:  Expert Rev Vaccines       Date:  2015-05-02       Impact factor: 5.217

3.  Vaccinia virus induces strong immunoregulatory cytokine production in healthy human epidermal keratinocytes: a novel strategy for immune evasion.

Authors:  Luzheng Liu; Zhan Xu; Robert C Fuhlbrigge; Victor Peña-Cruz; Judy Lieberman; Thomas S Kupper
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

4.  Sequential generalized likelihood ratio tests for vaccine safety evaluation.

Authors:  Mei-Chiung Shih; Tze Leung Lai; Joseph F Heyse; Jie Chen
Journal:  Stat Med       Date:  2010-11-20       Impact factor: 2.373

Review 5.  Application of pharmacogenomics to vaccines.

Authors:  Gregory A Poland; Inna G Ovsyannikova; Robert M Jacobson
Journal:  Pharmacogenomics       Date:  2009-05       Impact factor: 2.533

Review 6.  Adversomics: the emerging field of vaccine adverse event immunogenetics.

Authors:  Gregory A Poland; Inna G Ovsyannikova; Robert M Jacobson
Journal:  Pediatr Infect Dis J       Date:  2009-05       Impact factor: 2.129

Review 7.  Personalized vaccines: the emerging field of vaccinomics.

Authors:  Gregory A Poland; Inna G Ovsyannikova; Robert M Jacobson
Journal:  Expert Opin Biol Ther       Date:  2008-11       Impact factor: 4.388

8.  Formulation of Nanovaccines toward an Extended Immunity against Nicotine.

Authors:  Yun Hu; Zongmin Zhao; Marion Ehrich; Chenming Zhang
Journal:  ACS Appl Mater Interfaces       Date:  2021-06-09       Impact factor: 10.383

9.  Analysis of known bacterial protein vaccine antigens reveals biased physical properties and amino acid composition.

Authors:  Carl Mayers; Melanie Duffield; Sonya Rowe; Julie Miller; Bryan Lingard; Sarah Hayward; Richard W Titball
Journal:  Comp Funct Genomics       Date:  2003

10.  Longitudinal investigation of public trust in institutions relative to the 2009 H1N1 pandemic in Switzerland.

Authors:  Adrian Bangerter; Franciska Krings; Audrey Mouton; Ingrid Gilles; Eva G T Green; Alain Clémence
Journal:  PLoS One       Date:  2012-11-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.